Zacks Investment Research
04 Aug 2026, 23:31 UTC · 2h ago
Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
04 Aug 2026, 23:31 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Amgen reported a quarterly EPS of $6.29, beating the Zacks Consensus Estimate of $5.60 by 12.32%. — A significant double-digit earnings beat typically drives immediate positive price action for the specific ticker.
+0.60Amgen's quarterly revenue reached $10.05 billion, exceeding the Zacks Consensus Estimate of $9.44 billion by 6.52%. — Revenue beats indicate strong top-line growth and market demand, reinforcing the positive earnings surprise.
+0.40Amgen's quarterly revenue increased 9.5% year-over-year. — Steady year-over-year growth confirms a positive trajectory for the company's fundamental scale.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company reported revenue and EPS that both significantly beat Zacks Consensus Estimates and showed year-over-year growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
38m ago
